Sort
50,496 grants matching “lung cancer”
Infections, immunity, and inflammation in cancer
$1,085,068Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Molecular Signatures of Lung Cancer
$1,084,715David P Carbone · Vanderbilt University · U01 · FY2010 · CA
Thoracic Cancer Research Laboratory
$1,084,453Giuseppe Giaccone · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer
$1,084,271Ramaswamy Govindan · Washington University · U01 · FY2022 · CA
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$1,083,650Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
NYU Lung Cancer Biomarker Center
$1,082,162William N Rom · New York University School Of Medicine · U01 · FY2009 · CA
Immune modulation of radiation therapy with Flt3 ligand
$1,081,749Tibor Keler · Celldex Therapeutics, Inc. · R44 · FY2015 · CA
Mechanistic Targeting of Lung Cancer
$1,081,162Lucy M Anderson · Basic Sciences · Z01 · FY2007 · CA
Regulation Of Intracellular Iron Metabolism
$1,080,971Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
Functions and Mechanisms of NF-kB Factors and their Regulators
$1,080,903Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Advancing cancer care and equity through telehealth, communication science, and behavioral economics
$1,080,625Katharine A. Rendle · University Of Pennsylvania · P50 · FY2024 · CA
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
$1,080,326Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2015 · CA
DCTD Screening Technologies
$1,080,000Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)
$1,079,739Trever G Bivona · University Of California, San Francisco · U54 · FY2025 · CA
CCR, LGI, Flow Cytometry Core Facility
$1,078,977Karen Wolcott · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Targeting the DNA Damage Response sensor Replication Protein A for first inclass cancer therapy
$1,078,680Katherine Pawelczak · Nerx Biosciences, Inc. · R44 · FY2024 · CA
Molecular Cytogenetics of Solid Tumors
$1,078,567Nicolae Popescu · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial
$1,078,239Lance L Yokochi · Pacific Health Research Institute · N01 · FY2009 · CA
Detroit Research on Cancer Survivors (Detroit ROCS)
$1,077,655Ann G Schwartz · Wayne State University · U01 · FY2022 · CA
ASIAN AMERICAN NETWORK FOR CANCER AWARENESS RESEARCH & TRAINING
$1,077,511Moon S Chen · University Of California At Davis · U01 · FY2009 · CA
Center on Probes for Molecular Mechanotechnology
$1,077,182Khalid S. Salaita · Emory University · RM1 · FY2024 · GM
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negativebacterial infections
$1,076,832David S Perlin · Hackensack University Medical Center · R01 · FY2022 · AI
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negative bacterial infections
$1,076,832David S Perlin · Hackensack University Medical Center · R01 · FY2021 · AI
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$1,076,811Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Vaccine and radiation for the therapy of human cancers
$1,076,634James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA